140 related articles for article (PubMed ID: 12133820)
1. Lipoprotein metabolism in the nephrotic syndrome.
Marsh JB
Front Biosci; 2002 Aug; 7():e326-38. PubMed ID: 12133820
[TBL] [Abstract][Full Text] [Related]
2. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
Vaziri ND
Kidney Int; 2016 Jul; 90(1):41-52. PubMed ID: 27165836
[TBL] [Abstract][Full Text] [Related]
3. Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome.
Tarugi P; Nicolini S; Albertazzi L; Calandra S; Salvati P; Ferti C; Patrono C
J Lipid Res; 1991 Oct; 32(10):1675-87. PubMed ID: 1797947
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
[TBL] [Abstract][Full Text] [Related]
5. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
Breier C; Lisch HJ; Drexel H; Braunsteiner H
Schweiz Med Wochenschr; 1983 Jun; 113(25):909-13. PubMed ID: 6612272
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein metabolism in experimental nephrosis.
Marsh JB
Proc Soc Exp Biol Med; 1996 Nov; 213(2):178-86. PubMed ID: 8931662
[TBL] [Abstract][Full Text] [Related]
7. Catabolism of very low density lipoproteins in experimental nephrosis.
Garber DW; Gottlieb BA; Marsh JB; Sparks CE
J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
[TBL] [Abstract][Full Text] [Related]
8. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
Vaziri ND; Liang KH
Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
[TBL] [Abstract][Full Text] [Related]
9. Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin.
Calandra S; Tarugi P; Ghisellini M; Gherardi E
Exp Mol Pathol; 1983 Dec; 39(3):282-99. PubMed ID: 6416889
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome.
Stenvinkel P; Berglund L; Ericsson S; Alvestrand A; Angelin B; Eriksson M
Eur J Clin Invest; 1997 Feb; 27(2):169-77. PubMed ID: 9061312
[TBL] [Abstract][Full Text] [Related]
11. Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis.
Marsh JB; Sparks CE
J Clin Invest; 1979 Nov; 64(5):1229-37. PubMed ID: 227928
[TBL] [Abstract][Full Text] [Related]
12. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome.
Shearer GC; Stevenson FT; Atkinson DN; Jones H; Staprans I; Kaysen GA
Kidney Int; 2001 Jan; 59(1):179-89. PubMed ID: 11135070
[TBL] [Abstract][Full Text] [Related]
13. Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome.
Braschi S; Masson D; Rostoker G; Florentin E; Athias A; Martin C; Jacotot B; Gambert P; Lallemant C; Lagrost L
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2559-67. PubMed ID: 9409228
[TBL] [Abstract][Full Text] [Related]
14. Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis.
Kaysen GA
Miner Electrolyte Metab; 1992; 18(2-5):212-6. PubMed ID: 1465061
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.
Joven J; Simó JM; Vilella E; Camps J; Espinel E; Villabona C
Clin Chem; 1995 Jun; 41(6 Pt 1):908-13. PubMed ID: 7768011
[TBL] [Abstract][Full Text] [Related]
16. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
Shafrir E
Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
[TBL] [Abstract][Full Text] [Related]
17. Effect of simvastatin on plasma lipid and lipoprotein concentrations and low-density lipoprotein metabolism in the nephrotic syndrome.
Warwick GL; Packard CJ; Murray L; Grierson D; Stewart JP; Shepherd J; Boulton-Jones JM
Clin Sci (Lond); 1992 Jun; 82(6):701-8. PubMed ID: 1320552
[TBL] [Abstract][Full Text] [Related]
18. Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome.
Calandra S; Gherardi E; Fainaru M; Guaitani A; Bartosek I
Biochim Biophys Acta; 1981 Aug; 665(2):331-8. PubMed ID: 6793079
[TBL] [Abstract][Full Text] [Related]
19. Plasma lipids and acyltransferase activities in experimental nephrotic syndrome.
Sestak TL; Alavi N; Subbaiah PV
Kidney Int; 1989 Aug; 36(2):240-8. PubMed ID: 2779094
[TBL] [Abstract][Full Text] [Related]
20. High density lipoproteinuria in nephrotic syndrome.
de Mendoza SG; Kashyap ML; Chen CY; Lutmer RF
Metabolism; 1976 Oct; 25(10):1143-9. PubMed ID: 184367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
